Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to DLBCL
Related studies linked through entity extraction aliases.
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Diet, Physical Activity and Body Composition Changes During R-CHOP
- Status
- WITHDRAWN
- Phase
- N/A
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
- Status
- TERMINATED
- Phase
- PHASE2
Split-Dose R-CHOP for Older Adults With DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers?
- Status
- COMPLETED
- Phase
- N/A
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)
- Status
- COMPLETED
- Phase
- PHASE1
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2